Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
- PMID: 37751017
- PMCID: PMC10600084
- DOI: 10.1007/s40121-023-00869-z
Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
Abstract
Introduction: Invasive meningococcal disease (IMD) due to serogroup W meningococci (MenW) is consistently reported with atypical clinical manifestations, including gastrointestinal symptoms, bacteremic pneumonia, and septic arthritis. We undertook a systematic review of the literature for a comprehensive assessment of the clinical presentation of IMD caused by MenW.
Methods: PubMed and Embase databases were searched from inception to June 2022 using a combination of MeSH terms and free text for articles that reported symptoms and signs of MenW IMD, and associated manifestations.
Results: The most commonly reported symptoms identified included: fever (range 36-100% of cases), nausea and/or vomiting (range 38-47%), vomiting (range 14-68%), cough (range 7-57%), sore throat (range 13-34%), headache (range 7-50%), diarrhea (range 8-47%), altered consciousness/mental status (range 7-38%), stiff neck (range 7-54%), and nausea (range 7-20%). Sepsis (range 15-83% of cases) was the most commonly reported manifestation followed by meningitis (range 5-72%), sepsis and meningitis (range 6-74%), bacteremic pneumonia (range 4-24%), arthritis (range 1-15%), and other manifestations (e.g., pharyngitis/epiglottitis/supraglottitis/tonsillitis/conjunctivitis; range 1-24%). The case fatality rates ranged from 8-40%, and among the survivors 4-14% had long-term sequelae.
Conclusions: Clinicians need to be aware of the nonspecific symptoms and signs of IMD, as well as of the atypical manifestations in regions where MenW is known to circulate to ensure timely diagnoses and treatment.
Keywords: Invasive meningococcal disease; Serogroup W; Symptoms.
© 2023. The Author(s).
Conflict of interest statement
I.B-G., L.F., and F.C. are employees of Sanofi and may hold shares and/or stock options in the company. R.E.G. is an employee of inScience Communications, Springer Healthcare Ltd, UK, which was contracted by Sanofi to undertake the literature search and provide editorial assistance. M.K.T. performs contract work for the Institut Pasteur funded by GSK, Pfizer, and Sanofi, and has a patent (NZ630133A) with GSK “vaccines for serogroup X meningococcus” issued.
Figures
Similar articles
-
Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci.Epidemiol Infect. 2020 Jan 27;148:e12. doi: 10.1017/S0950268819002152. Epidemiol Infect. 2020. PMID: 31983356 Free PMC article.
-
Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016.Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30175. Euro Surveill. 2016. PMID: 27035055
-
Meningococcal pericarditis caused by the MenW:cc11 strain in an older adult.Acta Clin Belg. 2023 Jun;78(3):254-256. doi: 10.1080/17843286.2022.2107315. Epub 2022 Jul 29. Acta Clin Belg. 2023. PMID: 35904255
-
Clinical manifestations of invasive meningococcal disease in Victoria with the emergence of serogroup W and serogroup Y Neisseria meningitidis.Intern Med J. 2021 Mar;51(3):390-397. doi: 10.1111/imj.14771. Intern Med J. 2021. PMID: 32043702
-
Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis.Vaccine. 2019 May 9;37(21):2768-2782. doi: 10.1016/j.vaccine.2019.04.020. Epub 2019 Apr 13. Vaccine. 2019. PMID: 30987851
Cited by
-
Infection invasive à méningocoque accompagnée de ténosynovite.CMAJ. 2024 Nov 3;196(37):E1270-E1273. doi: 10.1503/cmaj.240259-f. CMAJ. 2024. PMID: 39496355 Free PMC article. French. No abstract available.
-
Invasive meningococcal disease presenting with tenosynovitis.CMAJ. 2024 Sep 15;196(30):E1038-E1040. doi: 10.1503/cmaj.240259. CMAJ. 2024. PMID: 39284609 Free PMC article. No abstract available.
References
-
- World Health Organization. Meningitis. 2022; [cited 2022 Aug 1]. Available at: https://www.who.int/health-topics/meningitis#tab=tab_1.
-
- European Centre for Disease Prevention and Control. Factsheet about meningococcal disease. 2022; [cited 2022 Aug 1]. Available at: https://www.ecdc.europa.eu/en/meningococcal-disease/factsheet.
-
- European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC. Annual Epidemiological Report for 2018. Stockholm: ECDC; 2022; [cited 2023 Aug 28]. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/AER-Invasive-me....
Publication types
LinkOut - more resources
Full Text Sources